Pharmafile Logo
Pharmafocus logo
Advanced Search
nick_plaquetec_c-4

PlaqueTec appoints Dr Nick West as CMO

November 24, 2015
Research and Development PlaqueTec

PlaqueTec has appointed Dr Nick West as its new chief medical officer.  Dr West is a research-active clinician with extensive …

Appointment
opdivo

FDA approves BMS’s Opdivo for renal cell carcinoma

November 24, 2015
Research and Development

The FDA has approved Bristol Myers Squibb’s immunotherapy Opdivo for the treatment of patients with advanced renal cell carcinoma (RCC). …

News
Arzerra

Genmab pulls plug on Phase III Arzerra trial

November 24, 2015
Manufacturing and Production, Research and Development Arzerra, Genmab, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma, ofatumumab, phase III, phase III failure

Genmab has stopped a Phase III study of its CD20-directed monoclonal antibody Arzerra, after it was shown to be unlikely …

News
Catapult cell therapy

Construction for new £55m cell and gene manufacturing centre in Stevenage begins

November 24, 2015
Manufacturing and Production Catapult, Cell Therapy Catapult, Hertfordshire, gene therapy, manufacturing, stevenage

The Government-backed Cell Therapy Catapult has begun the construction for its cell and gene therapy manufacturing centre.   The construction …

News
Beximco logo

FDA approves Beximco to manufacture Carvedilol for US

November 24, 2015
Manufacturing and Production Bangladesh, Beximco, Carvediol, FDA, exports, generics

Beximco Pharmaceuticals has become the first Bangladeshi pharma company to receive approval for a prescription drug to be manufactured in …

News
EU flag

Novartis and Amgen drugs signed-off by European Commission

November 24, 2015
Manufacturing and Production Amgen, Entresto, European Commission, Novartis, blincyto

The European governing body, the European Commission, has approved the Novartis drug Entresto for heart failure and Amgen’s Blincyto for …

News
NN Tianjin plant

Novo Nordisk to go green by 2020

November 24, 2015
Manufacturing and Production Novo Nordish, manufacturing, production, renewable energy

Novo Nordisk has announced plans to go green in the next five years by using only electricity from renewable sources …

News

OmniaMed UK appoints new senior management

November 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …

Appointment
merck-sharp--dohme-corp

MSD launches new antibiotic in the UK

November 23, 2015
Manufacturing and Production, Research and Development

Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …

News

Dr Clive Deverson

November 23, 2015

OmniaMed UK appoints new senior management OmniaMed strengthens its senior management team by appointing Dr Clive Deverson as Managing Director …

Appointment
tablets_red

Take the Pharmafocus reader survey today

November 23, 2015
Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …

Feature
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015
Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …

News
Takeda oncology

FDA approves Takeda’s Ninlaro for multiple myeloma

November 23, 2015
Manufacturing and Production, Research and Development Takeda, myeloma

The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …

News
pfizer_logo

Pfizer and Allergan on brink of $150 billion merger

November 23, 2015
Sales and Marketing

Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …

News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015
Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …

News
horizon_pharma

Horizon withdraws $1bn Depomed bid

November 20, 2015
Sales and Marketing

Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …

News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015
Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …

News
ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015
Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …

News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015
Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …

News
martin_shkreli_smaller_same

Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares

November 20, 2015
Medical Communications, Research and Development

KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …

Appointment
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026